Sandoz is recalling 10 lots of its generic oral contraceptive Introvale in the US, because of a packaging flaw.
The possibility that the packaging flaw will cause serious adverse health consequences are remote, and there are no reports to date of any adverse event. The recall is being made as a precautionary measure to minimize any potential of patients being impacted.
The lots were distributed only in the United States and were distributed between January 2011 and May 2012.